ALPS Medical Breakthroughs ETF $SBIO Shares Sold by Phoenix Wealth Advisors

Phoenix Wealth Advisors cut its stake in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) by 62.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,902 shares of the company’s stock after selling 16,204 shares during the period. Phoenix Wealth Advisors’ holdings in ALPS Medical Breakthroughs ETF were worth $385,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Raymond James Financial Inc. purchased a new position in shares of ALPS Medical Breakthroughs ETF in the second quarter worth $82,000. Ally Invest Advisors Inc. acquired a new position in shares of ALPS Medical Breakthroughs ETF in the 2nd quarter valued at $200,000. Moran Wealth Management LLC purchased a new position in ALPS Medical Breakthroughs ETF in the 2nd quarter worth $300,000. Sterling Investment Advisors Ltd. purchased a new position in ALPS Medical Breakthroughs ETF in the 3rd quarter worth $315,000. Finally, Jones Financial Companies Lllp acquired a new stake in ALPS Medical Breakthroughs ETF during the 1st quarter worth about $782,000.

ALPS Medical Breakthroughs ETF Price Performance

Shares of SBIO stock opened at $51.07 on Friday. The stock’s 50-day simple moving average is $49.72 and its 200-day simple moving average is $41.24. ALPS Medical Breakthroughs ETF has a fifty-two week low of $22.33 and a fifty-two week high of $52.90.

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.